东阳光药(06887.HK)拟实施H股全流通

Core Viewpoint - Dongyang Sunshine Pharmaceutical (06887.HK) announced the board's approval to convert 251,378,534 domestic shares held by certain shareholders into H-shares, representing approximately 43.59% of the total issued share capital as of the announcement date [1] Group 1 - The proposed conversion of domestic shares into H-shares is subject to approval from the China Securities Regulatory Commission and the Hong Kong Stock Exchange [1]